Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/12/2019
SIETES contiene 92848 citas

 
 
 1 a 20 de 1045 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
McQuaid J. Asthma takes a hard toll on African-Americans. Can precision medicine ease the burden?. STAT Daily Recap 2019:26 de marzo. [Ref.ID 103064]
2.Enlace a cita original Cita con resumen
Kloprogge F, Workman L, Bormann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Martensson A, Ngasala B, Björkman A, Ashton M, Hietala SF, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Bames KI, Tarning J. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLOS Medicine 2018:12 de junio. [Ref.ID 102769]
3. Cita con resumen
4.Enlace a cita original Cita con resumen
Lanoiselée J, Zufferey PJ, Ollier E, Hoding S, Delavenne X, for the PeriOpeRative Tranexamic acid in hip arthrOplasty (PORTO) study investigators. Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic–pharmacodynamic study . Br J Clin Pharmacol 2018;84:febrero. [Ref.ID 102534]
5. Cita con resumen
Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016;375:1638-48. [Ref.ID 100914]
6. Cita con resumen
Anónimo. Interactions with herbal products: what do we know?. Drug Ther Bull 2014;52:18-21. [Ref.ID 97104]
7. Cita con resumen
Klumpers LE, Fridberg M, de Kam ML, Little PB, Jensen NO, Kleinloog HD, Elling CE, van Gerven JM. Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects. Br J Clin Pharmacol 2013;76:846-57. [Ref.ID 96629]
9. Cita con resumen
Homberg MT, Tornio A, Joutsi-Korhonen L, Neuvonen M, Neuvonen PJ, Lassila R, Niemi M, Backman JT. Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. Br J Clin Pharmacol 2013;75:1488-96. [Ref.ID 95569]
10. Cita con resumen
Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med 2013;173:611-2. [Ref.ID 95286]
11.Tiene citas relacionadas
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.. Arthritis Care Res (Hoboken) 2012;64:1431-6. [Ref.ID 94310]
12.Tiene citas relacionadas Cita con resumen
Gurbel PA, Erlinge D, Ohman EM, Neely B, Neely M, Goodman SG, Huber K, Chan MY, Cornel JH, Brown E, Zhou C, Jakubowski JA, White HD, Fox KAA, Prabhakaran D, Armstrong PW, Tantry US, Roe MT, for the TRILOGY ACS Platelet Function Substudy Investigators. Platelet function extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: The TRILOGY ACS Platelet Function Substudy. JAMA 2012;308:1785-94. [Ref.ID 94020]
13.Enlace a cita original Cita con resumen
Clemens A, Van Ryn J, Sennewald R, Yamamura N, Stangier J, Feuring M, Härtter S. Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol 2012;68:607-16. [Ref.ID 92819]
14.Tiene citas relacionadas Cita con resumen
Li GL, Winter H, Arends R, Jay GW, Le V, Young T, Huggins JP. Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. Br J Clin Pharmacol 2012;73:706-16. [Ref.ID 92795]
15. Cita con resumen
Anónimo. Deferiprone (Ferriprox) for iron overload. Med Lett Drugs Ther 2012;54:15-6. [Ref.ID 92429]
16.Enlace a cita originalTiene citas relacionadas
Kazmi RS, Lwaleed BA. New anticoagulants: how to deal with treatment failure and bleeding complications. Br J Clin Pharmacol 2011;72:593-603. [Ref.ID 91566]
17.Enlace a cita originalTiene citas relacionadas
Lee CJ, Ansell JE. Direct thrombin inhibitors. Br J Clin Pharmacol 2011;72:581-92. [Ref.ID 91565]
18.Enlace a cita originalTiene citas relacionadas
Toschi V, Lettino M. Inhibitors of propagation of coagulation: factors V and X. Eur J Clin Pharmacol 2011;72:563-80. [Ref.ID 91564]
19.Enlace a cita originalTiene citas relacionadas
Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Eur J Clin Pharmacol 2011;72:553-62. [Ref.ID 91563]
20.Enlace a cita originalTiene citas relacionadas
Ott I. Inhibitors of the initiation of coagulation. Eur J Clin Pharmacol 2011;72:547-52. [Ref.ID 91562]
Seleccionar todas
 
 1 a 20 de 1045 siguiente >>